Full-Time

Customer Therapeutic Area Report Lead

Posted on 1/24/2023

BenchSci

BenchSci

201-500 employees

Biomedical AI research software

Data & Analytics
AI & Machine Learning

Senior

Toronto, ON, Canada

Requirements
  • Scientific subject matter expertise in one of the following areas: neurodegenerative diseases, cardiovascular diseases, or cardiometabolic diseases
  • Ph.D. or MSc +3 years of relevant bench experience in life sciences (e.g. Molecular Biology, Pharmacology)
  • Previous experience working as a scientific liaison or in management consulting with client management
  • Demonstrated project management abilities through project scoping, resource allocation, and prioritisation to meet all requirements and delivery timelines
  • Experience with people management and comfortable taking on a team with direct reports
  • Experience working with large datasets and working with data processing tools, such as Excel (can maintain complex spreadsheets), SQL, and Python/R
Responsibilities
  • Be the subject matter expert for the therapeutic area and BenchSci
  • Be the lead when communicating scientific/technical product requirements for data and clients
  • Provide scientific insights to support our client reports by extracting and analysing both internal and external data
  • Engage external partners in the exchange of scientific information for the relevant therapeutic area
  • Demonstrate excellent scientific knowledge and maintain relationships with clients, by communicating
  • Collect feedback and define opportunities to improve the development of BenchSci applications based on the proof-of-concept reports
  • Be accountable for all data requirements and ensure they are met for each delivery, Manage and grow your Science support team

BenchSci's mission is to exponentially increase the speed and quality of life-saving research by empowering scientists with the world's most advanced biomedical artificial intelligence. The company is currently building on their success with antibodies to address other critical reagents—including recombinant proteins, siRNAs, and CRISPR tools—as well as model systems such as animal models and cell lines.

Company Stage

Series D

Total Funding

$169.7M

Headquarters

Toronto, Canada

Founded

2015

Growth & Insights
Headcount

6 month growth

-12%

1 year growth

-6%

2 year growth

43%

Benefits

Remote-first culture

Equity options

15 days vacation + additional day every year

Unlimited flex time

Comprehensive health & dental benefits

Psychotherapist services

Annual Learning & Development budget

Home office set-up budget

Wellness, lifestyle & productivity spending account

INACTIVE